Predictions
DAVIDsTEA Inc
Start price
Target price
Perf. (%)
€4.18
06.02.21
06.02.21
-
06.02.22
06.02.22
-37.32%
07.02.22
07.02.22
Could be worthwhile Investment >10% per year
Walgreens Boots Alliance Inc.
Start price
Target price
Perf. (%)
€41.23
05.02.21
05.02.21
-
05.02.22
05.02.22
10.85%
13.06.21
13.06.21
HelloFresh SE
Start price
Target price
Perf. (%)
€74.20
03.02.21
03.02.21
€100.00
2.76%
12.02.21
12.02.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Sinopharm Group Co Ltd
Start price
Target price
Perf. (%)
€2.04
03.01.21
03.01.21
€2.40
03.01.22
03.01.22
-1.42%
04.01.22
04.01.22
Casino Guichard Inh.
Start price
Target price
Perf. (%)
€25.51
29.12.20
29.12.20
€28.00
29.12.21
29.12.21
-17.40%
20.10.21
20.10.21
Could be worthwhile Investment >10% per year
Rallye S.A.
Start price
Target price
Perf. (%)
€5.88
27.12.20
27.12.20
€6.50
27.12.21
27.12.21
-20.24%
20.11.21
20.11.21
Could be worthwhile Investment >10% per year
HelloFresh SE
Start price
Target price
Perf. (%)
€62.30
18.12.20
18.12.20
€70.00
5.94%
07.01.21
07.01.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
United Natural Foods
Start price
Target price
Perf. (%)
€13.07
17.12.20
17.12.20
€14.50
17.12.21
17.12.21
231.75%
18.12.21
18.12.21
HelloFresh SE
Start price
Target price
Perf. (%)
€60.30
15.12.20
15.12.20
€55.00
3.32%
18.12.20
18.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
HelloFresh SE
Start price
Target price
Perf. (%)
€49.62
29.11.20
29.11.20
€108.00
29.11.21
29.11.21
87.51%
30.11.21
30.11.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bad rating
HelloFresh SE
Start price
Target price
Perf. (%)
€41.64
16.11.20
16.11.20
€34.00
16.11.21
16.11.21
19.16%
29.11.20
29.11.20
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bad rating
Shanghai Pharmceuticals
Start price
Target price
Perf. (%)
€1.46
16.11.20
16.11.20
€1.80
16.11.21
16.11.21
3.94%
17.11.21
17.11.21